BioCentury
ARTICLE | Finance

Going long in genomics

Why 10x thinks it has game-changing technology for DNA sequencing

March 21, 2016 7:00 AM UTC

After raising $110.5 million in just over a year, 10x Genomics and its investors think the company has all the fuel it needs to become independent of the financial markets.

Last week 10x topped up with $55 million in a series C round led by new investor Fidelity. Other new investors Softbank and JS Capital joined founding investors Venrock, Foresite Capital and Paladin Capital. ...